Replies to post #9268 on GTC Biotherapeutics (fka GTCB)

[keitern]

Jonhbits, thought provoking comments.

>>GTCB is one mistake away from not existing<<

What would ameliorate these concerns? Takeover by a big player, duplicate farms for redundancy, or some other?

>>GTC methods aren't cheap when you factor in having to get approved on a new method of production<<

I don't understand this point.

>>... and factor in the liablity of having two methods of producing a drug like Tysabri. For instance, if someone got PML from a GTC batch of Tysabri, how would Elan determine what the real problem was? Was it something GTC did or was a basic problem with Tysabri?<<

I don't see this as a real concern but maybe I am missing it.